Need a Reliable Peptide Supplier? Click HERE!!!SponsoredVisit ↗
Kisspeptin-10 and BAC Water Mix

Kisspeptin-10 Reconstitution Calculator

Enter the amount you want to measure. The vial buttons will highlight which vial strengths create cleaner syringe-unit measurements.

What amount do you need?

Type the target amount, then choose mg or mcg. Example: 2mg or 500mcg.

Work the dose out from body weight

Syringe size:
Possible vial strengths:
Best Match Good Match Usable Harder to Measure

Example Kisspeptin-10 Titration Schedule

ItemDetails
Dose100–200 mcg per injection
Frequency2–3× per week
Critical ruleNever twice-daily beyond 2 weeks
Female timingFollicular phase, stop after trigger

The 2–3×/week rhythm is the one human protocol shown to sustain LH/FSH elevation (twice-daily dosing caused complete tachyphylaxis by day 14 in the controlled trial). Trial doses are nmol/kg-based; microgram conversions are unvalidated.

Possible vial strengths:

What Is It?

Kisspeptin-10

Kisspeptin fragment studied in reproductive signaling.

Bacteriostatic Water

Sterile water containing a bacteriostatic preservative, commonly used when preparing multi-use research vials.

How To Mix Kisspeptin-10

1
Clean

Use alcohol swabs to clean the tops of both vials.

2
Draw BAC Water

Draw the selected amount of bacteriostatic water.

3
Inject Slowly

Add the liquid slowly down the side of the vial.

4
Swirl Gently

Do not shake. Swirl gently until dissolved.

5
Store Properly

Store as directed and protect from heat and light.

Best Practices & Common Mistakes

Best Practices

  • Use sterile technique.
  • Protect from light and heat.
  • Store refrigerated when appropriate.
  • Use clean syringe-unit math before measuring.

Common Mistakes

  • Confusing milligrams with milliliters.
  • Choosing an option with awkward decimal units.
  • Using too little liquid for very small measurements.
  • Shaking the vial aggressively.

Kisspeptin-10 Storage & Handling

Lyophilized Powder: −20°C (−4°F) for long-term storage (up to 24 months). Refrigeration 2–8°C (36–46°F) for short-term use (up to ~3 months). Original sealed vial in the freezer is safest.
Reconstituted Solution: 2–8°C (36–46°F), use within ~7–14 days. Keep sealed, avoid light, and do not repeat freeze-thaw cycles.

Frequently Asked Questions

Kisspeptin-10 is a 10-amino-acid neuropeptide (the active C-terminal fragment of kisspeptin-54, encoded by the KISS1 gene) that sits at the very top of the reproductive hormone cascade. It binds the KISS1R (GPR54) receptor on GnRH neurons in the hypothalamus — it's the switch that tells those neurons to fire, initiating the whole chain that drives puberty, fertility, and sexual function. It is an investigational research peptide, not an approved drug.
It can raise testosterone, but indirectly and briefly: kisspeptin-10 switches on hypothalamic GnRH neurons, which release GnRH in its natural pulsatile pattern, prompting the pituitary to put out LH and FSH, which then drive the gonads. Because it's the most potent known trigger of GnRH neurons, even small amounts spark an LH surge. But its plasma half-life is only about 4 minutes, so its effect is short-lived and continuous high-dose exposure can blunt the receptor rather than help.
The three act at three different levels of the same chain. Kisspeptin-10 is highest up — it stimulates the hypothalamus to release its own GnRH; gonadorelin is one step down — it is GnRH, acting directly on the pituitary; and hCG is lowest — it mimics LH at the gonads, skipping the brain entirely. So kisspeptin is the most "upstream" and physiological trigger, while hCG is the most direct. They are not the same and aren't interchangeable.
Its most distinctive research area is sexual function: Imperial College studies found kisspeptin increased activity in brain regions tied to sexual arousal and improved subjective "happiness about sex," including in people with low desire — a brain-and-hormone effect that sets it apart from pure axis drugs. It's also studied as an IVF ovulation trigger (potentially with less risk of ovarian hyperstimulation), and in hypothalamic amenorrhea and menopausal hot flashes. All of this is early-stage (Phase 1/2) human research, not established treatment.
Reconstitute the lyophilized powder with bacteriostatic water: for a 5 mg vial, adding 4 mL gives 1.25 mg/mL, so a 250 mcg amount draws to 0.2 mL (20 units on a U-100 syringe); adjust the water volume to suit your dosing. It is not FDA-approved — only investigational and sold as a research compound — with limited human safety data and no established long-term profile, so fertility, testosterone, or libido concerns belong with a clinician. Storage: keep the dry powder cold and dark, and refrigerate reconstituted solution, using it within a few weeks.
Practical takeaway: If your goal involves weight management, metabolic health, recovery, physical performance, cognitive function, appearance, or general well-being, discuss it with a licensed healthcare professional. They can help you evaluate approved, evidence-based options rather than relying on an unapproved or investigational compound. This calculator is intended only for transparent research-reference calculations and does not determine an appropriate amount, recommend use, or replace professional medical guidance.

About the author

Maria Hrabina is a pharmacist and scientific reviewer with a strong interest in peptide science, pharmacology, and emerging therapeutic compounds.

Her work focuses on understanding how peptide-based compounds interact with biological signaling pathways and how they are being investigated across areas such as metabolic health, dermatology, recovery, regenerative research, and pharmaceutical development.

Maria follows research on a broad range of peptides, from compounds used in approved medicines to experimental molecules still being evaluated in laboratory, preclinical, and clinical studies.

Her approach combines scientific curiosity with critical evaluation of evidence. She believes promising mechanisms and early research deserve attention, but should not be presented as established clinical benefits until they are supported by adequate human data.

Her areas of focus include scientific literature review, mechanisms of action, pharmacology, pharmacokinetics, safety, pharmaceutical formulation, and the overall quality of evidence behind peptide-based compounds.

She is particularly interested in the process of translating an experimental molecule into a reliable pharmaceutical product — including compound characterization, purity, stability, formulation, dose selection, safety assessment, and controlled clinical trials.

Maria believes peptide science has significant long-term potential, but that its progress depends on rigorous research, high manufacturing standards, transparent safety data, and responsible scientific communication.

Through her writing, she aims to help readers understand both sides of peptide research: what makes these compounds scientifically promising and what questions remain before their potential can be considered clinically established.

Areas of interest: Peptide Science · Therapeutic Peptides · Peptide Pharmacology · Metabolic Peptides · Cosmetic Peptides · Drug Development · Pharmacokinetics · Drug Safety · Pharmaceutical Formulation · Emerging Therapies · Evidence-Based Medicine

Important: This tool is for informational and research-reference purposes only. Not intended for human or veterinary use.
← All peptides